Clik here to view.
Meropenem...Cubist Antibiotic Passes Second Test; FDA Filing Next
Meropenem3-[5-(dimethylcarbamoyl) pyrrolidin-2-yl] sulfanyl-6- (1-hydroxyethyl)-4-methyl-7-oxo- 1-azabicyclo[3.2.0] hept-2-ene-2-carboxylic CAS 119478-56-7Cubist Pharmaceuticals (CBST) reported good...
View ArticleClik here to view.
sergliflozin
408504-26-7 cas noSergliflozin etabonate (INN/USAN,[1][2] codenamed GW869682X) is an investigational anti-diabetic drug being developed by GlaxoSmithKline. It did not undergo further development after...
View ArticleFDA Approves Anoro Ellipta to Treat Chronic Obstructive Pulmonary Disease
December 18, 2013 -- The U.S. Food and Drug Administration today approved Anoro Ellipta (umeclidinium and vilanterol inhalation powder) for the once-daily, long-term maintenance treatment of airflow...
View ArticleNovo Nordisk Files NDA, MAA for Victoza for Obesity
Novo Nordisk files for regulatory approval of liraglutide 3 mg for the treatment of obesity Bagsværd, Denmark, 20 December 2013 – Novo Nordisk today announced two separate regulatory submissions for a...
View ArticleClik here to view.
Daclatasvir
DaclatasvirBMS-790052, EBP 883; BMS 790052cas no 1009119-64-5THERAPEUTIC CLAIM Treatment of hepatitis C CHEMICAL NAMES 1. Carbamic acid,...
View ArticleClik here to view.
Biota Reports That Laninamivir Octanoate is Approved for the Prevention of...
Biota Reports That Laninamivir Octanoate is Approved for the Prevention of Influenza in Japan « New Drug Approvals: 'via Blog this'
View Article